The " stone-like" pattern of LC3A expression and its clinicopathologic significance in hepatocellular carcinoma

Biochemical and Biophysical Research Communications

Volumn 431, Issue 4, 2013, Pages 760-766

  Xi, Shao Yan ^a   Lu, Jia Bin ^a   Chen, Jie Wei ^a   Cao, Yun ^a   Luo, Rong Zhen ^a   Wu, Qiu Liang ^a   Cai, Mu Yan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

" Stone like"; Hepatocellular carcinoma; IHC; LC3A; Prognosis

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORRELATIONAL STUDY; CYTOPLASM; DATA ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875241014     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.151     Document Type: Article

References (31)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2007, 57:43-66.
2. Cai M.Y., Tong Z.T., Zheng F., Liao Y.J., Wang Y., Rao H.L., Chen Y.C., Wu Q.L., Liu Y.H., Guan X.Y., Lin M.C., Zeng Y.X., Kung H.F., Xie D. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies. Gut 2011, 60:967-976.
3. Yuen M.F., Cheng C.C., Lauder I.J., Lam S.K., Ooi C.G., Lai C.L. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000, 31:330-335.
4. Hsu Y.C., Fu H.H., Jeng Y.M., Lee P.H., Yang S.D. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma. J. Clin. Oncol. 2006, 24:3780-3788.
5. Mizushima N., Ohsumi Y., Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct. Funct. 2002, 27:421-429.
6. Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290:1717-1721.
7. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
8. Kabeya Y., Mizushima N., Yamamoto A., Oshitani-Okamoto S., Ohsumi Y., Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 2004, 117:2805-2812.
9. He H., Dang Y., Dai F., Guo Z., Wu J., She X., Pei Y., Chen Y., Ling W., Wu C., Zhao S., Liu J.O., Yu L. Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J. Biol. Chem. 2003, 278:29278-29287.
10. Marino G., Lopez-Otin C. Autophagy: molecular mechanisms, physiological functions and relevance in human pathology. Cell. Mol. Life Sci. 2004, 61:1439-1454.
11. Sivridis E., Koukourakis M.I., Zois C.E., Ledaki I., Ferguson D.J., Harris A.L., Gatter K.C., Giatromanolaki A. LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am. J. Pathol. 2010, 176:2477-2489.
12. Sivridis E., Giatromanolaki A., Liberis V., Koukourakis M.I. Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS): what is destined for the atypical endometrial hyperplasia?. Autophagy 2011, 7:74-82.
13. Giatromanolaki A., Koukourakis M.I., Harris A.L., Polychronidis A., Gatter K.C., Sivridis E. Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J. Clin. Pathol. 2010, 63:867-872.
14. Karpathiou G., Sivridis E., Koukourakis M.I., Mikroulis D., Bouros D., Froudarakis M.E., Giatromanolaki A. Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas. Chest 2011, 140:127-134.
15. Sivridis E., Giatromanolaki A., Karpathiou G., Karpouzis A., Kouskoukis C., Koukourakis M.I. LC3A-positive " stone-like" structures in cutaneous squamous cell carcinomas. Am. J. Dermatopathol. 2011, 33:285-290.
16. Edmondson H.A., Steiner P.E. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954, 7:462-503.
17. Sobin L.H., Fleming I.D. TNM Classification of Malignant Tumors, fifth edition. Cancer 1997, 80:1803-1804.
18. Cai M.Y., Hou J.H., Rao H.L., Luo R.Z., Li M., Pei X.Q., Lin M.C., Guan X.Y., Kung H.F., Zeng Y.X., Xie D. High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients. Mol. Med. 2011, 17:12-20.
19. Cai M.Y., Zhang B., He W.P., Yang G.F., Rao H.L., Rao Z.Y., Wu Q.L., Guan X.Y., Kung H.F., Zeng Y.X., Xie D. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Sci. 2010, 101:1543-1549.
20. Zhu W., Cai M.Y., Tong Z.T., Dong S.S., Mai S.J., Liao Y.J., Bian X.W., Lin M.C., Kung H.F., Zeng Y.X., Guan X.Y., Xie D. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymal transition. Gut 2012, 61:562-575.
21. Levine B. Cell biology: autophagy and cancer. Nature 2007, 446:745-747.
22. Kirisako T., Baba M., Ishihara N., Miyazawa K., Ohsumi M., Yoshimori T., Noda T., Ohsumi Y. Formation process of autophagosome is traced with Apg8/Aut7p in yeast. J. Cell. Biol. 1999, 147:435-446.
23. Notte A., Leclere L., Michiels C. Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem. Pharmacol. 2011, 82:427-434.
24. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 2005, 5:726-734.
25. Vazquez-Martin A., Oliveras-Ferraros C., Menendez J.A. Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab. PLoS One 2009, 4:e6251.
26. Bellodi C., Lidonnici M.R., Hamilton A., Helgason G.V., Soliera A.R., Ronchetti M., Galavotti S., Young K.W., Selmi T., Yacobi R., Van Etten R.A., Donato N., Hunter A., Dinsdale D., Tirro E., Vigneri P., Nicotera P., Dyer M.J., Holyoake T., Salomoni P., Calabretta B. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 2009, 119:1109-1123.
27. Shi Y.H., Ding Z.B., Zhou J., Hui B., Shi G.M., Ke A.W., Wang X.Y., Dai Z., Peng Y.F., Gu C.Y., Qiu S.J., Fan J. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 2011, 7:1159-1172.
28. Othman E.Q., Kaur G., Mutee A.F., Muhammad T.S., Tan M.L. Immunohistochemical expression of MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues. J. Clin. Lab. Anal. 2009, 23:249-258.
29. Yoshioka A., Miyata H., Doki Y., Yamasaki M., Sohma I., Gotoh K., Takiguchi S., Fujiwara Y., Uchiyama Y., Monden M. LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers. Int. J. Oncol. 2008, 33:461-468.
30. Fujii S., Mitsunaga S., Yamazaki M., Hasebe T., Ishii G., Kojima M., Kinoshita T., Ueno T., Esumi H., Ochiai A. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci. 2008, 99:1813-1819.
31. Aoki H., Kondo Y., Aldape K., Yamamoto A., Iwado E., Yokoyama T., Hollingsworth E.F., Kobayashi R., Hess K., Shinojima N., Shingu T., Tamada Y., Zhang L., Conrad C., Bogler O., Mills G., Sawaya R., Kondo S. Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy 2008, 4:467-475.